GlassScriptPhysician profile
Michelle Boudria
NPI 1578641445
$1,773.00
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $481 · 2022: $1,106 · 2023: $168 · 2024: $18.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $410.59 | 2021-2023 | Veltassa |
| Horizon Therapeutics Plc | $345.97 | 2021-2023 | Krystexxa |
| Bayer Healthcare Pharmaceuticals INC. | $202.58 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $196.68 | 2021-2022 | |
| Medtronic, INC. | $65.53 | 2022 | |
| Glaxosmithkline, LLC. | $59.68 | 2022-2024 | Benlysta |
| Travere Therapeutics, INC. | $54.49 | 2022 | |
| Boston Scientific Corporation | $53.98 | 2022 | |
| Opko Pharmaceuticals, LLC | $53.32 | 2021-2022 | |
| Daiichi Sankyo INC. | $50.83 | 2021 | |
| Calliditas Therapeutics US INC. | $47.63 | 2022 | |
| Mallinckrodt Hospital Products INC. | $45.77 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $43.71 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $27.75 | 2021 | |
| Bard Peripheral Vascular, INC. | $23.21 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $20.58 | 2021 | |
| Akebia Therapeutics INC | $19.70 | 2022 | |
| Amgen INC. | $19.19 | 2022 | |
| Xeris Pharmaceuticals, INC. | $15.92 | 2022 | |
| Ani Pharmaceuticals, INC. | $15.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Boudria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.